Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/10/2025 ,inter alia, to consider and approve It is proposed to consider early redemption ....
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biocon Ltd has informed the stock exchanges that its Board of Directors will meet on October 1, 2025, to consider the early redemption of 1,07,000 unlisted, secured, rated, redeemable Non-Convertible Debentures (NCDs) of face value ₹1,00,000 each, totaling approximately ₹1,070 crore. These NCDs were originally issued and allotted on a private placement basis on February 21, 2023. The early redemption is subject to Board approval and receipt of other necessary approvals. The intimation was filed under Regulation 29(1)(h) of SEBI Listing Regulations and signed by Mukesh Kamath, Interim CFO.
If approved, early redemption of ~₹1,070 crore of NCDs before maturity signals proactive deleveraging and could reduce future interest costs for Biocon, which is generally viewed positively by investors as it strengthens the balance sheet.